by Richard Daverman, PhD
November 6, 2012 -- Zhongyuan Union Stem Cell Bioengineering Co. has signed a memorandum of understanding to set up a stem cell JV with Cell Therapy Ltd. of Wales. The JV, which will have $8 million in startup capital, will use stromal (connective tissue) cells from the germinal layer to treat heart failure. Cell Therapy Ltd. was founded by the 2007 Nobel laureate for Medicine, Sir Martin Evans. More details....
Stock Symbol: (SHA: 600645)
